• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用时间权衡法估算罗马尼亚的 EQ-5D-3L 值集。

Estimating an EQ-5D-3L Value Set for Romania Using Time Trade-Off.

机构信息

Romanian Academic Society, 020071 Bucharest, Romania.

Department of Pharmacology, Titu Maiorescu University, 031593 Bucharest, Romania.

出版信息

Int J Environ Res Public Health. 2021 Jul 11;18(14):7415. doi: 10.3390/ijerph18147415.

DOI:10.3390/ijerph18147415
PMID:34299864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8306594/
Abstract

OBJECTIVE

To provide health-related quality of life (HRQoL) data to support health technology assessment (HTA) and reimbursement decisions in Romania, by developing a country-specific value set for the EQ-5D-3L questionnaire.

METHODS

We used the cTTO method to elicit health state values using a computer-assisted personal interviewing approach. Interviews were standardized following the most recent version of the EQ-VT protocol developed by the EuroQoL Foundation. Thirty EQ-5D-3L health states were randomly assigned to respondents in blocks of three. Econometric modeling was used to estimate values for all 243 states described by the EQ-5D-3L.

RESULTS

Data from 1556 non-institutionalized adults aged 18 years and older, selected from a national representative sample, were used to build the value set. All tested models were logically consistent; the final model chosen to generate the value set was an interval regression model. The predicted EQ-5D-3L values ranged from 0.969 to 0.399, and the relative importance of EQ-5D-3L dimensions was in the following order: mobility, pain/discomfort, self-care, anxiety/depression, and usual activities.

CONCLUSIONS

These results can support reimbursement decisions and allow regional cross-country comparisons between health technologies. This study lays a stepping stone in the development of a health technology assessment process more driven by locally relevant data in Romania.

摘要

目的

通过为 EQ-5D-3L 问卷开发特定于罗马尼亚的效用值量表,为罗马尼亚的卫生技术评估(HTA)和报销决策提供与健康相关的生活质量(HRQoL)数据。

方法

我们使用 cTTO 方法通过计算机辅助个人访谈方法来获取健康状态值。访谈按照 EuroQoL 基金会开发的最新版 EQ-VT 协议进行标准化。受访者将随机分配到 3 个一组的 30 个 EQ-5D-3L 健康状态中。使用计量经济学模型来估算 EQ-5D-3L 描述的所有 243 个状态的价值。

结果

该效用值量表是基于全国代表性样本中 1556 名 18 岁及以上非住院成年人的数据构建的。所有测试的模型在逻辑上都是一致的;最终选择的生成效用值量表的模型是区间回归模型。预测的 EQ-5D-3L 值范围从 0.969 到 0.399,EQ-5D-3L 维度的相对重要性依次为:行动能力、疼痛/不适、自我护理、焦虑/抑郁和日常活动。

结论

这些结果可以支持报销决策,并允许在罗马尼亚进行地区间跨国的卫生技术比较。这项研究为罗马尼亚发展更依赖于本地相关数据的卫生技术评估过程奠定了基石。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6826/8306594/6da59e005f7f/ijerph-18-07415-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6826/8306594/c39d7fd78a56/ijerph-18-07415-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6826/8306594/358328ccb6fd/ijerph-18-07415-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6826/8306594/6da59e005f7f/ijerph-18-07415-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6826/8306594/c39d7fd78a56/ijerph-18-07415-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6826/8306594/358328ccb6fd/ijerph-18-07415-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6826/8306594/6da59e005f7f/ijerph-18-07415-g003.jpg

相似文献

1
Estimating an EQ-5D-3L Value Set for Romania Using Time Trade-Off.使用时间权衡法估算罗马尼亚的 EQ-5D-3L 值集。
Int J Environ Res Public Health. 2021 Jul 11;18(14):7415. doi: 10.3390/ijerph18147415.
2
A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.一种用于获取健康状态偏好的混合建模方法:葡萄牙 EQ-5D-5L 值集。
Qual Life Res. 2019 Dec;28(12):3163-3175. doi: 10.1007/s11136-019-02226-5. Epub 2019 Jun 14.
3
EQ-5D-5L: a value set for Romania.EQ-5D-5L:罗马尼亚的一套价值体系。
Eur J Health Econ. 2023 Apr;24(3):399-412. doi: 10.1007/s10198-022-01481-7. Epub 2022 Jun 10.
4
Value Set for the EQ-5D-Y-3L in Hungary.匈牙利的 EQ-5D-Y-3L 量表值。
Pharmacoeconomics. 2022 Dec;40(Suppl 2):205-215. doi: 10.1007/s40273-022-01190-2. Epub 2022 Sep 20.
5
Estimating an EQ-5D-Y-3L Value Set for Indonesia by Mapping the DCE onto TTO Values.基于离散选择实验(DCE)到时间权衡(TTO)值的映射来估计印度尼西亚的 EQ-5D-Y-3L 值集。
Pharmacoeconomics. 2022 Dec;40(Suppl 2):157-167. doi: 10.1007/s40273-022-01210-1. Epub 2022 Nov 9.
6
Measuring health-related quality of life in the general population and Roma communities in Romania: study protocol for two cross-sectional studies.在罗马尼亚的普通人群和罗姆社区中测量与健康相关的生活质量:两项横断面研究的研究方案。
BMJ Open. 2019 Aug 18;9(8):e029067. doi: 10.1136/bmjopen-2019-029067.
7
Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary.匈牙利通过时间贸易偏好法对 EQ-5D-3L 和 EQ-5D-5L 进行平行评估。
Value Health. 2020 Sep;23(9):1235-1245. doi: 10.1016/j.jval.2020.03.019. Epub 2020 Aug 12.
8
Population norms for the EQ-5D-3L and EQ-5D-5L in Romania.罗马尼亚人群的 EQ-5D-3L 和 EQ-5D-5L 量表常模。
Health Qual Life Outcomes. 2023 Jul 29;21(1):80. doi: 10.1186/s12955-023-02144-8.
9
Estimating an EQ-5D-Y-3L Value Set for Brazil.估算巴西的 EQ-5D-Y-3L 值集。
Pharmacoeconomics. 2024 Sep;42(9):1047-1063. doi: 10.1007/s40273-024-01404-9. Epub 2024 Jul 2.
10
Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.欧洲五维健康量表青年版(EQ-5D-Y)和欧洲五维健康量表 3 级版(EQ-5D-3L)健康状态的估值:措辞和视角的影响。
Value Health. 2018 Nov;21(11):1291-1298. doi: 10.1016/j.jval.2018.05.002. Epub 2018 Aug 8.

引用本文的文献

1
A Head-On Comparison of EQ-VT- and Crosswalk-Based EQ-5D-5L Value Sets.基于EQ-VT和人行横道法的EQ-5D-5L值集的直接比较。
Appl Health Econ Health Policy. 2025 Mar 11. doi: 10.1007/s40258-025-00954-z.
2
Valuation of the EQ-5D-3L in Jordan.约旦EQ-5D-3L量表的估值
Eur J Health Econ. 2025 Apr;26(3):487-501. doi: 10.1007/s10198-024-01712-z. Epub 2024 Sep 3.
3
The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands.EORTC QLU-C10D 是一种在荷兰具有成本效用和卫生技术评估有效性的癌症特异性偏好测量工具。

本文引用的文献

1
Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary.匈牙利通过时间贸易偏好法对 EQ-5D-3L 和 EQ-5D-5L 进行平行评估。
Value Health. 2020 Sep;23(9):1235-1245. doi: 10.1016/j.jval.2020.03.019. Epub 2020 Aug 12.
2
Measuring health-related quality of life in the general population and Roma communities in Romania: study protocol for two cross-sectional studies.在罗马尼亚的普通人群和罗姆社区中测量与健康相关的生活质量:两项横断面研究的研究方案。
BMJ Open. 2019 Aug 18;9(8):e029067. doi: 10.1136/bmjopen-2019-029067.
3
Cultural Values: Can They Explain Differences in Health Utilities between Countries?
Eur J Health Econ. 2024 Dec;25(9):1539-1555. doi: 10.1007/s10198-024-01670-6. Epub 2024 Mar 14.
4
Population norms for the EQ-5D-3L and EQ-5D-5L in Romania.罗马尼亚人群的 EQ-5D-3L 和 EQ-5D-5L 量表常模。
Health Qual Life Outcomes. 2023 Jul 29;21(1):80. doi: 10.1186/s12955-023-02144-8.
5
In search of a 'pan-European value set'; application for EQ-5D-3L.寻找“泛欧价值体系”;EQ-5D-3L 的应用。
BMC Med Res Methodol. 2023 Jan 12;23(1):13. doi: 10.1186/s12874-022-01830-3.
6
Conceptual Framework for Optimised Proxy Value Set Selection Through Supra-National Value Set Development for the EQ-5D Instruments.通过超国家 EQ-5D 工具值集开发优化代理值集选择的概念框架。
Pharmacoeconomics. 2022 Dec;40(12):1221-1234. doi: 10.1007/s40273-022-01194-y. Epub 2022 Oct 6.
7
EQ-5D-5L: a value set for Romania.EQ-5D-5L:罗马尼亚的一套价值体系。
Eur J Health Econ. 2023 Apr;24(3):399-412. doi: 10.1007/s10198-022-01481-7. Epub 2022 Jun 10.
文化价值观:它们能否解释国家间健康效用的差异?
Med Decis Making. 2019 Jul;39(5):605-616. doi: 10.1177/0272989X19841587. Epub 2019 Jul 1.
4
Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol.概述、更新以及从国际 EQ-5D-5L 估值工作中吸取的经验教训:EQ-5D-5L 估值议定书第 2 版。
Value Health. 2019 Jan;22(1):23-30. doi: 10.1016/j.jval.2018.05.010. Epub 2019 Jan 2.
5
Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.平行评估:EQ-5D-3L 和 EQ-5D-5L 社会价值集的直接比较。
Med Decis Making. 2018 Nov;38(8):968-982. doi: 10.1177/0272989X18802797.
6
Drug Policy in Romania.罗马尼亚的毒品政策。
Value Health Reg Issues. 2018 Sep;16:28-32. doi: 10.1016/j.vhri.2017.11.003. Epub 2018 Apr 26.
7
Interim EQ-5D-5L Value Set for Poland: First Crosswalk Value Set in Central and Eastern Europe.波兰的临时EQ-5D-5L价值集:中东欧首个交叉价值集。
Value Health Reg Issues. 2014 Sep;4:19-23. doi: 10.1016/j.vhri.2014.06.001. Epub 2014 Jul 8.
8
Selecting Health States for EQ-5D-3L Valuation Studies: Statistical Considerations Matter.选择 EQ-5D-3L 估值研究中的健康状态:统计考虑至关重要。
Value Health. 2018 Apr;21(4):456-461. doi: 10.1016/j.jval.2017.09.001. Epub 2017 Oct 18.
9
Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review.中东欧国家的药品监管:当前综述
Front Pharmacol. 2017 Dec 18;8:892. doi: 10.3389/fphar.2017.00892. eCollection 2017.
10
A Comparison of Iran and UK EQ-5D-3L Value Sets Based on Visual Analogue Scale.伊朗和英国 EQ-5D-3L 价值集的视觉模拟量表比较。
Int J Health Policy Manag. 2017 May 1;6(5):267-272. doi: 10.15171/ijhpm.2016.131.